Current status and future challenges in T-cell receptor/peptide/MHC molecular dynamics simulations
Open Access
- 28 February 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 16 (6) , 1035-1044
- https://doi.org/10.1093/bib/bbv005
Abstract
The interaction between T-cell receptors (TCRs) and major histocompatibility complex (MHC)-bound epitopes is one of the most important processes in the adaptive human immune response. Several hypotheses on TCR triggering have been proposed. Many of them involve structural and dynamical adjustments in the TCR/peptide/MHC interface. Molecular Dynamics (MD) simulations are a computational technique that is used to investigate structural dynamics at atomic resolution. Such simulations are used to improve understanding of signalling on a structural level. Here we review how MD simulations of the TCR/peptide/MHC complex have given insight into immune system reactions not achievable with current experimental methods. Firstly, we summarize methods of TCR/peptide/MHC complex modelling and TCR/peptide/MHC MD trajectory analysis methods. Then we classify recently published simulations into categories and give an overview of approaches and results. We show that current studies do not come to the same conclusions about TCR/peptide/MHC interactions. This discrepancy might be caused by too small sample sizes or intrinsic differences between each interaction process. As computational power increases future studies will be able to and should have larger sample sizes, longer runtimes and additional parts of the immunological synapse included.Keywords
This publication has 65 references indexed in Scilit:
- A structural voyage toward an understanding of the MHC‐I‐restricted immune response: lessons learned and much to be learnedImmunological Reviews, 2012
- The structural basis of αβ T‐lineage immune recognition: TCR docking topologies, mechanotransduction, and co‐receptor functionImmunological Reviews, 2012
- The Present and Future of Peptide Vaccines for CancerThe Cancer Journal, 2011
- T Cell Epitope-Based Allergy VaccinesPublished by Springer Nature ,2011
- Mechanisms for T cell receptor triggeringNature Reviews Immunology, 2010
- Conformational Flexibility in Designing Peptides for Immunology: The Molecular Dynamics ApproachCurrent Computer-Aided Drug Design, 2010
- A critical cross-validation of high throughput structural binding prediction methods for pMHCJournal of Computer-Aided Molecular Design, 2009
- Side chain substitution benchmark for peptide/MHC interactionProtein Science, 2008
- More than one reason to rethink the use of peptides in vaccine designNature Reviews Drug Discovery, 2007
- HOW TCRS BIND MHCS, PEPTIDES, AND CORECEPTORSAnnual Review of Immunology, 2006